FIELD: medicine.
SUBSTANCE: invention refers to biotechnology and virology. What is described is a new varicella zoster virus (VZV) strain. Disclosed are genome DNA of the VZV strain MAV/06 recovered from a Korean patient, its open reading frame (ORF) and proteins coded by the genome DNA of the VZV strain MAV/06 and related ORF. What is also described is a vaccine composition, which contains the above protein as an active component. The presented group of inventions is applicable in medicine.
EFFECT: what is described is the new varicella zoster virus strain.
11 cl, 10 dwg, 3 tbl, 2 ex
Authors
Dates
2016-04-10—Published
2012-02-24—Filed